RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: 2019 Letter to Shareholders, page-97

  1. ravanelli77
    2,872 Posts.
    lightbulb Created with Sketch. 285
    clock Created with Sketch.
    27/11/19
    18:10
    Post #: 41668342
    I feel that FDA decision will be ann in 2020. If mgt would be able to close deals one after the other it would be a very good and strong sign. But no deals and no FDA approval the longer it takes the more SP will drift back to low 20. IMO
    Last edited by ravanelli77: 27/11/19
    RAP Price at posting: 27.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.